How long can they keep the lid on the other vaccines?
The pharmaceutical giant recently announced a voluntary withdrawal of its Covid-19 vaccine globally, citing a surplus of other COVID-19 vaccines targeting new variants on the market and low demand for the company’s Oxford–AstraZeneca COVID‑19 vaccine, sold under the brand names Covishield and Vaxzevria.
The company has faced a mountain of lawsuits worldwide and has recently admitted in court that its COVID-19 vaccine can cause blood clots. However, what hasn’t been widely disclosed is AstraZeneca’s most recent Phase III two-year post-vaccine safety clinical trial study results, which is quite alarming.
Delusions of Adequacy 